Iron Saturation (Transferrin Saturation)
Iron saturation (transferrin saturation, TSAT) is the most clinically useful marker for assessing iron availability for erythropoiesis and should be interpreted alongside ferritin, with TSAT <20% indicating iron deficiency in most clinical contexts.
What TSAT Indicates
TSAT reflects iron immediately available for red blood cell production, calculated by dividing serum iron by total iron binding capacity (TIBC). Unlike ferritin (which reflects storage iron), TSAT directly measures functional iron availability 1.
Key diagnostic thresholds:
- TSAT <16%: Absolute iron deficiency in healthy individuals 1
- TSAT <20%: Iron deficiency in most clinical settings including CKD, heart failure, and general populations 1, 2
- TSAT remains elevated in hemochromatosis until iron stores are depleted 3
Clinical Context Matters
Without Inflammation
In patients without inflammatory conditions:
- TSAT <20% + ferritin <30 ng/mL: Absolute iron deficiency 4, 5
- TSAT <20% + ferritin 30-100 ng/mL: Likely iron deficiency 4, 5
- TSAT <20% + ferritin >100 ng/mL: Functional iron deficiency (iron stores present but unavailable) 1
With Inflammation
Critical pitfall: Ferritin is an acute phase reactant and becomes unreliable in inflammatory states (IBD, CKD, heart failure, obesity) 1, 4. In these conditions:
- TSAT <20% is the primary diagnostic criterion regardless of ferritin level 4, 6
- Ferritin <100 ng/mL + TSAT <20%: Iron deficiency in inflammatory conditions 4, 6
- TSAT distinguishes functional iron deficiency from inflammatory iron block 1
Disease-Specific Evaluation
Chronic Kidney Disease
- Absolute iron deficiency: TSAT ≤20% + ferritin ≤100 μg/L (predialysis/peritoneal dialysis) or ≤200 μg/L (hemodialysis) 1, 6
- Functional iron deficiency common with erythropoietin therapy 1
Heart Failure
Recent evidence challenges traditional criteria 7, 8:
- TSAT <20% (with ferritin <400 μg/L) is the validated criterion for identifying patients who benefit from IV iron 8
- Low TSAT predicts mortality and hospitalization; ferritin levels do not 7, 8
- Patients with TSAT <20% show 33% risk reduction in cardiovascular death/HF hospitalization with IV iron; those with TSAT ≥20% show no benefit 8
- Discard ferritin <100 ng/mL as a standalone criterion in heart failure 8
Hemochromatosis
- TSAT typically remains elevated until iron depletion occurs 3
- Target ferritin 50-100 μg/L with phlebotomy; TSAT normalizes as stores deplete 3
Inflammatory Bowel Disease
- Without inflammation: ferritin <30 μg/L or TSAT <16% indicates iron deficiency 4
- With inflammation: ferritin <100 μg/L or TSAT <16% indicates iron deficiency 4
Management Based on TSAT
TSAT <20%
Initiate iron replacement:
- Oral iron: First-line for most patients; every-other-day dosing improves absorption 9, 10
- IV iron: Preferred for heart failure (improves outcomes), CKD on dialysis, intolerance to oral iron, or malabsorption 2, 9, 6
- Recheck CBC and iron parameters 4-8 weeks after treatment (not within 4 weeks of IV iron due to assay interference) 2
TSAT ≥20%
- If ferritin <100 ng/mL without inflammation: Consider trial of oral iron 5
- If ferritin >100 ng/mL: Unlikely to benefit from iron supplementation unless functional deficiency suspected 1
Monitoring Strategy
Post-treatment evaluation 2:
- Hemoglobin should increase 1-2 g/dL within 4-8 weeks
- Target TSAT >20% and ferritin 50 ng/mL (without inflammation) or 100 ng/mL (with inflammation)
- Frequency depends on underlying cause: monthly for ongoing blood loss, annually for stable conditions
Common Pitfalls to Avoid
- Do not rely on ferritin alone in inflammatory conditions - TSAT is more reliable 1, 4
- Do not check iron parameters within 4 weeks of IV iron - circulating iron interferes with assays 2
- Do not use ferritin <100 ng/mL as sole criterion in heart failure - TSAT <20% is the validated marker 8
- Do not assume TSAT >20% excludes all iron deficiency - functional deficiency can occur with adequate TSAT in specific contexts 1